news

Nov 17, 2026

Stage M2 — Bioinformatic AI agents :sparkles:

6 mois · Laboratoire Biosciences et bioingénierie pour la santé (BGE) - IRIG - CEA · Grenoble (France)

Context-aware AI agents for bioinformatics: building context-specific knowledge graphs from the literature to generate directional predictions from differential expression analyses. See the project page.

Nov 16, 2026

New article in PLOS One

Calculation of sequence space coverage in a mutagenesis library

A. Florez Prada, G. Uguzzoni, D. J. Hart — PLOS One 21(11): e0362864 (2026).

Nov 04, 2026

New article in ACS Omega

Integrated Whole-Cell Phage Display and Machine Learning Identify Candidate Targeting Ligands in KRAS-Defined Lung Cancer Contexts

G. Uguzzoni, D. C. Belisario, A. Pagnani, S. Marchiò — ACS Omega (2026).

Whole-cell phage display on a panel of lung cancer cell lines with different KRAS backgrounds, combined with a probabilistic model of selection, to identify peptides associated with KRAS-mutant contexts. See the project page.

May 10, 2026

PhD position

Université Grenoble Alpes · CEA Grenoble · Starting October 2026

Integrative AI models for therapeutic peptide design

Combining experimental fitness landscapes with generative structural design.

Host lab: BGE — Biosciences & Bioengineering for Health
Doctoral school: ED ISCE - UGA

Therapeutic peptides are an emerging class of biologics, with nearly one hundred approved drugs, capable of modulating protein–protein interactions that conventional small molecules cannot reach. This project develops AI-driven computational methods to design peptides against two targets of major public health relevance. Influenza is estimated by the WHO to cause 290,000 to 650,000 respiratory deaths globally each year, and antimicrobial resistance (AMR) was associated with an estimated 4.95 million deaths worldwide in 2019 (1.27 million directly attributable), and is designated by the WHO among the top ten global public health threats. In both cases, peptides offer a promising but under-exploited therapeutic modality, and the bottleneck is no longer synthesis or screening but the design of candidates that simultaneously satisfy affinity, selectivity and safety constraints. The methods developed in this PhD aim to address this bottleneck and, beyond the two case studies, to produce a general framework transferable to other peptide and protein design problems.

Mar 01, 2026

Hackathon on Predictive Modeling in Systems Pharmacology

CEA Grenoble, 17-20 March 2026

Join us for an intensive 3.5 days Hackathon designed to bridge the gap between theory and practice in Systems Pharmacology. Participants will explore diverse modeling frameworks and put them into action through collaborative and interdisciplinary challenges. Open to members of CANVAS and DIGPHAT consortia, aiming to foster interdisciplinary collaboration and cross-border expertise across Europe.

Sep 15, 2025

Stage M2 :sparkles:

6 mois, jan 2026 Laboratoire Biosciences et bioingénierie pour la santé - IRIG - CEA · Grenoble (France)

Nov 10, 2024

New manuscript in PLoS Computational Biology

Inference and design of antibody specificity: From experiments to models and back